Daily medication could soon be replaced with a once-a-month injection for people living with HIV thanks to advances in medical technology and extensive research.
The announcement follows the results of a study conducted by global ATLAS which looked at the results of a long-acting monthly injection that has shown to be as effective at suppressing HIV as a daily cocktail of three drugs.
The injection which includes a combination of two drugs, Cabotegravir and Rilpivirine, is being described as extremely effective, and may potentially be more effective in treating HIV that the current daily method.
With a monthly injection proving to be a more simple option, as opposed to taking ARV medication on a daily basis, researchers say that in turn with more people remembering or being able to take their medication, the more people on successful treatment will also reduce their HIV levels to undetectable, resulting in further reductions in infection rates.
According to WHO (the World Health Organisation) and UNAIDS, 36.7 million people were living with HIV across the globe at the end of 2016. South Africa is recorded as having the biggest HIV epidemic in the world, with 7.1 million people living with the virus.
Last Updated on Aug 19, 2018